Phn ng d ng nghim trng (sng da hoc c hng, kh nut, kh th, pht ban, tim p nhanh)
Cardiovascular and metabolic diseases including obesity remain important areas of unmet medical need, and we plan to continue applying our global capabilities to advance a pipeline of investigational treatments that have the potential to fill critical gaps in patient care, including continued development of our oral GIPR antagonist candidate and other earlier obesity programs, said Chris Boshoff, MD, PhD, Chief Scientific Officer and President, Research and Development at Pfizer
In contrast, dichloroacetate (DCA), a pyruvate dehydrogenase kinase inhibitor, only reduced IL-6 expression but did not affect IL-8, IL-1 and COX-2 expression induced by bTNF- in bFLS (Fig
As the evidence base solidifies, the future of OA care lies in personalization, tailoring nutritional plans based on genetics, gut microbiota, and individual metabolic profiles
L-Carnitine for Fat Loss: Why Most Supplements Fail (and What Actually Works) L-carnitine is an ingredient that has been on the supplement market for decades
